Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
0.9580
+0.0330 (3.57%)
At close: Aug 13, 2025, 4:00 PM
0.9800
+0.0220 (2.30%)
Pre-market: Aug 14, 2025, 8:22 AM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $18.36 million as of August 14, 2025. Its market cap has increased by 9.42% in one year.
Market Cap
18.36M
Enterprise Value
8.09M
1-Year Change
9.42%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $18.36M, a decrease of -97.09%. That is a compound annual growth rate of -55.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 18.36M | -46.21% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |